Skip to main content
SpringerLink
Log in

Management of the Thyroid Nodule: A Comparison of Published International Guidelines

  • Chapter
  • First Online:
Thyroid Cancer

  • 211 Accesses

Abstract

The aim of this chapter is to summarize the available recommendations and to compare and contrast guidelines for management of thyroid nodules including those published by the European Thyroid Association (ETA) in 2006, the British Thyroid Association (BTA) in 2007, the National Cancer Institute (NCI) in 2008, the American Thyroid Association (ATA) in 2009, the Latin American Thyroid Society (LATS) in 2009, the French Thyroid Association (FTA) in 2011, and the National Comprehensive Cancer Network Guidelines in 2011.

There is consensus regarding the majority of diagnostic and therapeutic procedures for patients with thyroid nodules. There are few areas of disagreement, such as indications for scintigraphy or universal screening with calcitonin (CT). Finally, there are clinically relevant areas of uncertainty such as the routine application of molecular diagnostics for the risk stratification of indeterminate nodules, which remain to be addressed by further research and clinical experience.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787–803.

    Article  CAS  PubMed  Google Scholar 

  2. Guidelines for the management of thyroid cancer. British Thyroid Association. 2007; http://www.british-thyroid-association.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf.

  3. Pitman MB, Abele J, Ali SZ, Duick D, Elsheikh TM, Jeffrey RB, Powers CN, Randolph G, Renshaw A, Scoutt L. Techniques for thyroid FNA: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol. 2008;36(6):407–24.

    Article  PubMed  Google Scholar 

  4. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.

    Article  Google Scholar 

  5. Camargo R, Corigliano S, Friguglietti C, Gauna A, Harach R, Munizaga F, Niepomniszcze H, Pitoia F, Pretell E, Vaisman M, Ward LS, Wohllk N, Tomimori E, Latin American thyroid society. Latin American thyroid society recommendations for the management of thyroid nodules. Arq Bras Endocrinol Metabol. 2009;53(9):1167–75.

    Article  PubMed  Google Scholar 

  6. Wémeau JL, Sadoul JL, d’Herbomez M, Monpeyssen H, Tramalloni J, Leteurtre E, Borson-Chazot F, Caron P, Carnaille B, Léger J, Do C, Klein M, Raingeard I, Desailloud R, Leenhardt L. Guidelines of the French society of endocrinology for the management of thyroid nodules. Ann Endocrinol. 2011;72:251–81.

    Article  Google Scholar 

  7. Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Hunt JP, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Moley JF, Olson JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ. NCCN clinical practice guidelines in oncology: thyroid carcinoma version 3. 2011. http://www.nccn.org.

  8. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P, AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest. 2010;33(5 Suppl):1–50.

    CAS  PubMed  Google Scholar 

  9. Paschke R, Hegedüs L, Alexander E, Valcavi R, Papini E, Gharib H. Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol. 2011;7(6):354–61.

    Article  PubMed  Google Scholar 

  10. Herrmann BL, Schmid KW, Goerges R, Kemen M, Mann K. CT screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol. 2010;162:1141–5.

    Article  CAS  PubMed  Google Scholar 

  11. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grunwald F. Calculation and validation of a plasma CT limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid. 2009;19:327–32.

    Article  CAS  PubMed  Google Scholar 

  12. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum CT levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007;92:450–5.

    Article  CAS  PubMed  Google Scholar 

  13. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F. Impact of routine measurement of serum CT on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab. 2004;89:163–8.

    Article  CAS  PubMed  Google Scholar 

  14. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R, Pirich C. Frequency and relevance of elevated CT levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab. 2004;89:515–9.

    Article  CAS  PubMed  Google Scholar 

  15. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum CT levels. World J Surg. 2002;26:886–90.

    Article  PubMed  Google Scholar 

  16. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum CT in patients with thyroid disorders. Thyroid. 2005;15:1267–72.

    Article  CAS  PubMed  Google Scholar 

  17. Karga H, Giagourta I, Papaioannou G, Doumouchtsis K, Polymeris A, Thanou S, Papamichael K, Zerva C. Changes in risk factors and tumor node metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum CT. Metabolism. 2011;60:604–8.

    Article  CAS  PubMed  Google Scholar 

  18. Daniels GH. Screening for medullary thyroid carcinoma with serum CT measurements in patients with thyroid nodules in the United States and Canada. Thyroid. 2011;21(11):1199–207.

    Article  CAS  PubMed  Google Scholar 

  19. d’Herbomez M, Caron P, Bauters C, Cao CD, Schlienger JL, Sapin R, Baldet L, Carnaille B, We’meau JL, French Group GTE (Groupe des Tumeurs Endocrines). Reference range of serum CT levels in humans: influence of CT assays, sex, age, and cigarette smoking. Eur J Endocrinol. 2007;157:749–55.

    Article  PubMed  Google Scholar 

  20. Lyshchik A, Higashi T, Asato R, Tanaka S, Ito J, Mai JJ, Pellot-Barakat C, Insana MF, Brill AB, Saga T, Hiraoka M, Togashi K. Thyroid gland tumor diagnosis at US elastography. Radiology. 2005;237:202–11.

    Article  PubMed  Google Scholar 

  21. Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab. 2007;92:2917–22.

    Article  CAS  PubMed  Google Scholar 

  22. Tranquart F, Bleuzen A, Pierre-Renoult P, Chabrolle C, Sam Giao M, Lecomte P. Élastographie ultrasonore des lésions thyroïdiennes. J Radiol. 2008;89:35–9.

    Article  CAS  PubMed  Google Scholar 

  23. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves’ disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med. 1991;229:415–20.

    Article  CAS  PubMed  Google Scholar 

  24. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D. Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh). 1993;128:51–5.

    CAS  Google Scholar 

  25. Zhang S, Ivanovic M, Nemcek Jr AA, Defrias DV, Lucas E, Nayar R. Thin core needle biopsy crush preparations in conjunction with fine-needle aspiration for the evaluation of thyroid nodules: a complementary approach. Cancer. 2008;114:512–8.

    Article  PubMed  Google Scholar 

  26. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid. 1998;8:15–21.

    Article  CAS  PubMed  Google Scholar 

  27. Kini SR. Specimen adequacy and assessment, reporting system. In: Thyroid cytopathology: an atlas and text. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 17–26.

    Google Scholar 

  28. Wémeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, Vlaeminck-Guillem V. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo controlled trial by the French thyroid research group. J Clin Endocrinol Metab. 2002;87:4928–34.

    Article  PubMed  Google Scholar 

  29. Bonnema SJ, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Bastholt L, Hegedüs L. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab. 2007;92:3424–8.

    Article  CAS  PubMed  Google Scholar 

  30. Bonnema SJ, Nielsen VE, Hegedüs L. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH). Acta Oncol. 2006;45(8):1051–8.

    Article  CAS  PubMed  Google Scholar 

  31. Nielsen VE, Bonnema SJ, Jørgensen HB, Grupe P, Hegedüs L. Stimulation with 0,3 mg recombinant human thyrotropin (rhTSH) increases the effect of 131I therapy in patients with nontoxic nodular goiter. A prospective, randomized, double-blind trial – secondary publication. Ugeskr Laeger. 2006;168:4098–101.

    PubMed  Google Scholar 

  32. Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord. 2011;9(1):69–75.

    Article  PubMed  Google Scholar 

  33. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab. 1997;82:2862–6.

    Article  CAS  PubMed  Google Scholar 

  34. Mestman JH, Goodwin TM, Montoro MM. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am. 1995;24:41–71.

    CAS  PubMed  Google Scholar 

  35. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov Y, Pacini F, Randolph G, Sawka A, Shepard D, Sosa J, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Available online at Thyroid 25: DOI:10.1089/thy.2015.0020; print version in Thyroid 26:1–133, 2016.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Combined Divisions of Endocrinology, National Institutes of Health, Bethesda, MD, USA

    Joanna Klubo-Gwiezdzinska MD, PhD

Authors
  1. Joanna Klubo-Gwiezdzinska MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Klubo-Gwiezdzinska MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Medicine, MedStar Washington Hospital Center Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

  2. Nuclear Medicine Research MedStar Research Institute and Washington Hospital Center, Georgetown University School of Medicine Washington Hospital Center, Washington, DC, USA

    Douglas Van Nostrand

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Klubo-Gwiezdzinska, J. (2016). Management of the Thyroid Nodule: A Comparison of Published International Guidelines. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation